Recipient of federal assistance · NEW YORK, NY

SYNTHIS THERAPEUTICS, INC.

SYNTHIS THERAPEUTICS, INC. received $0 in federal grants and other assistance in FY2026, on 1 actions, −100% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $2.3M.

Assistance · FY2026
$0
New awards
0
Actions
1
Since FY2021
$2.3M
UEI
KC6RHFHRQAN6
Location
NEW YORK, NY
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 0FY2021
  2. -153.9KFY2022
  3. 453.8KFY2023
  4. 579KFY2024
  5. 1.4MFY2025
  6. 0FY2026

Top programs · Awarding agencies

Obligations in FY2026.

Largest awards

  1. IN VIVO EFFICACY, SAFETY AND PK/PD ANALYSIS OF SYN101, A FIRST IN CLASS, IMMUNE CELL TARGETED TGFB THERAPY FOR CANCER PATIENTS - NCI SBIR…$2M
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Sep 18, 2024 – Apr 28, 2026· R44CA291368

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.